Academy of Clinical Thyroidologists

Academy of Clinical Thyroidologists
Industry Clinical Medicine
Headquarters Washington,D.C USA
Key people
John Woody Sistrunk, M.D. President
Mark A. Lupo, M.D., F.A.C.E., E.C.N.U. Secretary
Website http://www.thyroidologists.org/

The Academy of Clinical Thyroidologists (ACT) was founded in May 2005 at the annual meeting of the Association of Clinical Endocrinologists (AACE) in Washington DC. The Academy is a professional society consisting of 32 members from the U.S. and Italy who specialize in clinical thyroidology. ACT enourages skill development in diagnostic and interventional ultrasound, nuclear thyroidology, and cytopathology to promote excellence in clinical practice and optimal outcomes for patients.[1]

Charter

The academy meets twice a year, and accepts board-certified new members who pledge to provide patients with state-of-the-art thyroid treatment; for example ultrasound, ultrasound guided biopsy, Interventional thyroid ultrasound to treat thyroid cysts, and cancer lymph nodes with ethanol, percutaneous ethanol injections (PEI), nuclear thyroid studies, such as I/123,131 uptakes, scans, and therapy doses of I/131 for Thyroid Cancer, Graves' disease, Toxic Nodular Goiter, and large obstructive Nontoxic Nodular Goiters.

Goals

Academy of Clinical Thyroidologists corroborates research and development in the field of endocrinology. The goals include:[2]

References

  1. "Goals and mission statement". Academy of Clinical Thyroidologists (ACT). Archived from the original on 27 June 2007. Retrieved 2007-07-04.
  2. "About us". ACT website. Retrieved 7 February 2014.

External links

This article is issued from Wikipedia - version of the Sunday, April 17, 2016. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.